SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 29 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 143 | -95.2% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 3,001 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 3,001 | -0.4% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 3,014 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -84.6% | 3,014 | -41.6% | 0.00% | – |
| Q3 2018 | $13,000 | – | 5,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |